Pharma channel feed

New FDA guid­ance gives man­u­fac­tur­ers lim­its for ni­trosamines

Last year
FDA+
Manufacturing

CDC vac­cine com­mit­tee votes unan­i­mous­ly to rec­om­mend Sanofi and As­traZeneca's RSV im­mu­niza­tion for ba­bies

Last year
Marketing

BAR­DA or­ders more small­pox and mpox vac­cines from Bavar­i­an Nordic

Last year
Deals
Manufacturing

Pfiz­er places a dozen prod­ucts on emer­gency or­der af­ter tor­na­do dam­age at North Car­oli­na plant

Last year

De­tails emerge on Cidara/J&J in­fluen­za part­ner­ship, with a count­down on next steps

Last year
Deals

Gala­pa­gos seeks 's­trate­gic op­tion­s' for Jy­s­e­le­ca as JAK in­hibitor sales dis­ap­point again

Last year

Gilead touts speed­i­er-than-ex­pect­ed pipeline ad­vances amid sol­id Q2 drug sales, ex­cept Covid-19 treat­ment Vek­lury

Last year

Cor­rect­ed: Ken­tucky takes PBMs to court over 'outra­geous' in­sulin prices

Last year
Law

Genen­tech up­dates spinal mus­cu­lar at­ro­phy ef­fort with new de­sign, so­cial me­dia and ‘Re­al Talk’

Last year
Marketing

FDA ex­pands Mer­ck­'s Ebo­la vac­cine ap­proval to chil­dren one year and old­er

Last year

FDA’s de­cen­tral­ized tri­al guid­ance: PhRMA, Mayo Clin­ic and oth­ers seek tweaks

Last year
FDA+

Re­gen­eron plans for quick re­de­ci­sion on CRL for high­er dose of Eylea

Last year
FDA+
Manufacturing

Up­dat­ed: Mod­er­na ramps up R&D spend in RSV, flu and cy­tomegalovirus in Q2

Last year

GSK, Pfiz­er head in­to patent du­el in high-stakes RSV vac­cine war

Last year
Law

Medicare may save $1.8B from four drugs in first year of price ne­go­ti­a­tions, re­search finds

Last year

FDA ap­proves Tai­ho's Lon­surf with be­va­cizum­ab for metasta­t­ic col­orec­tal can­cer

Last year
FDA+

BeiGene's BTK in­hibitor brings in $308M, dri­ves Q2 earn­ings with 46% in­crease from Q1

Last year

Third in line: Ed­i­tas says it may part­ner up on com­mer­cial­iza­tion of sick­le cell gene ther­a­py

Last year
Cell/Gene Tx

Te­va sees rev­enue in­creas­es in Q2 as it con­tin­ues its ‘piv­ot to growth’ dri­ve

Last year
Manufacturing

Mar­tin Shkre­li's old com­pa­nies se­cure $650,000 deal to sell Dara­prim amid bank­rupt­cy

Last year
Deals

Pro­QR finds eye dis­ease part­ner in Eu­rope, hands off two late-stage can­di­dates

Last year
Deals

Com­mon can­cer drug man­u­fac­tur­er warned by the FDA over da­ta in In­dia

Last year
FDA+
Manufacturing

Ab­b­Vie, Lund­beck ask FDA to re­vise draft guid­ance on mi­graine drugs

Last year
FDA+

Hen­ri­et­ta Lack­s' fam­i­ly set­tles lit­i­ga­tion with Ther­mo Fish­er for undis­closed amount over im­mor­tal cells

Last year
First page Previous page 109110111112113114115 Next page Last page
A service from the Financial Times